One of the most important innovative consumer channels in China, achieving a 5-fold growth in sales in 6 years, and achieving remarkable results with a box of chocolates
goodhellen
发表于 2024-4-3 15:44:30
3613
0
0
On April 2nd, the launch ceremony of Jiapei's new production season in 2024 officially opened at Hema. In recent years, the consumption of kiwifruit in the Chinese market has continued to rise, and it is expected to reach a new high this year. "Hema has become one of our most important innovative consumer channels," said Lu Tao, Vice President of Sales for Jiapei Greater China. Since the cooperation began in 2018, Hema's sales of Jiapei Kiwi have increased fivefold.
Chen Yanghui, the national fruit procurement and sales manager of Hema, said that through large-scale direct procurement, Hema, along with partners such as Jiapei and Jianong, has worked together to "lower" the price, allowing more consumers to taste the delicious and nutritious imported kiwifruit.
Retail expert Bao Yuezhong said that for mature large brand merchants like Jiapei, more emphasis is placed on channel innovation, which brings growth in sales, brand reputation, and other aspects. After joining forces with Jiapei, Hema's rapid growth for six consecutive years has not only led to an increase in orders, but also allowed Jiapei to leverage Hema's advantages in online and offline product promotion, showcasing new products to consumers through trial eating, offline activities, and other means.
For Hema, relying on direct procurement from the origin, lowering prices, continuously bringing in top-notch goods, and working together with strong partners to achieve a win-win situation. Exploring the unique fruits of China on one hand and laying out bases at overseas sources on the other have become two important measures for Hema to enrich its product categories and enhance its price competitiveness.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Sanofi: Targeted therapy drug for chronic obstructive pulmonary disease (COPD), Dabitou, approved in China
- General Motors Q3 sold over 420000 vehicles in China, surpassing gasoline powered vehicles for the first time in new energy vehicles
- Has the 'fixed price' policy been effective? General Motors' sales in China increased by 14.3% month on month in the third quarter, and SAIC GM's orders for certain models were overstocked
- Hyatt Hotels and China Resources Land establish a joint venture for light asset expansion, continuing to expand into the Chinese market
- The Boston Science Harbor Base has been completed and opened, achieving "independent production" in China
- When will Apple AI be launched in China? Cook responds!
- Tesla's third quarter profit exceeds expectations, Musk: Sales are expected to increase by 20-30% next year, and low-priced models will be launched in the first half of the year
- Dialogue with Meng Pu, Chairman of Qualcomm China: Qualcomm has long-term accumulation in China and will adhere to the path of self-developed chips
- This US funded enterprise has clarified its confidence and direction for development in China through the CIIE
- Pfizer's innovative targeted therapy drug Taizena has been approved in China
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 4 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 7 小时前
- 支持
- 反对
- 回复
- 收藏